Alpha Compute(ALP)
$2.31-0.15 (-5.92%)
ALP
Alpha Compute stock drug pipeline
$2.31
At close:-0.15 (-5.92%)
Want to see ALP full AI Analyst Report?
Alpha Compute (ALP) Drug Pipeline
267 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tt-10, Tt-4 | Endometrial Cancer, Ovarian Cancer, Non Small Cell Lung Cancer, Head And Neck Squamous Cell Carcinoma, Colorectal Cancer (Crc), Renal Cell Cancer, Castrate Resistant Prostate Cancer | phase1AndPhase2 | Recruiting | TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors | Jul 05, 2021 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tt-10, Tt-4 | phase1AndPhase2 | Endometrial Cancer, Ovarian Cancer, Non Small Cell Lung Cancer, Head And Neck Squamous Cell Carcinoma, Colorectal Cancer (Crc), Renal Cell Cancer, Castrate Resistant Prostate Cancer | Recruiting | TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors | Jul 05, 2021 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Alpha Compute Corp (ALP) have in its pipeline
Alpha Compute ALP is currently developing the following drugs: Tt-10, Tt-4. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

